Neurovascular Diagnostics, Inc.
Publicly observedBuffalo, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Buffalo | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Neurovascular Diagnostics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | TJDUDJHDFL31 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant16 Sept 2025Publicly observed
NIH SBIR/STTR award: Testing a Blood-Based Assay for Detection and Risk Assessment of Intracranial Aneurysms in Familial Cases
USD 266,097.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant16 Sept 2025Publicly observed
NIH SBIR/STTR award: Testing a Blood-Based Assay for Detection and Risk Assessment of Intracranial Aneurysms in Familial Cases
USD 430,957.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant30 Sept 2019Publicly observed
NIH SBIR/STTR award: Development of a Molecular Diagnostic to Identify Dangerous Intracranial Aneurysms
USD 834,755.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.